Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
The companies said in a statement the mRNA-based combination vaccine candidate was set to progress to a phase one trial in the United States with 180 volunteers.
The inoculation "could simplify immunisation practices against these two respiratory pathogens, potentially leading to better vaccine uptake for both diseases," said Annaliesa Anderson, head of vaccine research and development at US drugmaker Pfizer.
"Even with existing seasonal influenza vaccines, the burden of this virus is severe across the world, causing thousands of deaths and hospitalisations every year."
Pfizer and its German partner BioNTech developed one of the most widely used vaccines to combat Covid-19.
Rival vaccine makers Moderna and Novavax have also been testing combined inoculations against Covid and flu.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
CCTV Shows 3 Delhi Traffic Cops Diving 'Bribe' Money, Suspended
'Positive' Trial For Pfizer-BioNTech Covid-Flu Jab Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine What To Know About COVID-19 Vaccine For US Children Flower Seller Forced To Buy iPhone For Son On Hunger Strike, Internet Reacts "Trusted Mamata Banerjee But...": Father Of Murdered Doctor To NDTV "Like Indira Gandhi...": Student Arrested For 'Shoot Mamata Banerjee' Post US Man Recalls Moment Pilot Said He Didn't Have "Qualification" To Land Former Kolkata Hospital Principal At CBI Office For Day 4 Of Questioning "Makes Muslim Women's Condition Pathetic": Centre On Triple Talaq In Court Track Latest News Live on NDTV.com and get news updates from India and around the world.